After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Neumora Therapeutics Inc is $1.83B. A total of 0.94 million shares were traded on the day, compared to an average of 1.10M shares.
In the most recent transaction, Fust Matthew K sold 14,049 shares of NMRA for 17.03 per share on Oct 18 ’24. After the transaction, the Director now owns 20,100 company shares. In a previous transaction on Oct 17 ’24, Fust Matthew K sold 7,739 shares at 17.01 per share. NMRA shares that Director owns now total 20,100.
Among the insiders who bought shares, Fust Matthew K acquired of 14,049 shares on Oct 18 ’24 at a per-share price of $17.03. In another insider transaction, Fust Matthew K bought 7,739 shares at $17.01 per share on Oct 17 ’24.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, NMRA has a high of $21.00 and a low of $8.33.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NMRA’s latest balance sheet shows that the firm has $409.25M in Cash & Short Term Investments as of fiscal 2021. There were $2.05M in debt and $23.28M in liabilities at the time. Its Book Value Per Share was $2.00, while its Total Shareholder’s Equity was -$325.22M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NMRA is Buy with a score of 4.56.
